SOPH: Menu Philippe discloses a sale

By AlphaYouPublished Sep 23, 2026Form 4

Stocks in this disclosure

Reported activity

Menu Philippe

Reporting filer

Menu Philippe reported Sale in SOPHiA GENETICS SA: 5000 units of Ordinary Shares, dated 2026-09-14. The full Form 4 contains 1 transaction entry.

Disclosed: Sep 16, 2026

Reported details

1 entry

All validated entries in this disclosure
Security	Owner	Date	Code	Action	Quantity	Price	Following holdings	Reporting delay	Filed terms and references
Ordinary Shares	Menu Philippe	2026-09-14	S	Sale	5000	7.8833	208,387	2 days	Filed terms security Title: Ordinary Shares transaction Date: 2026-09-14 transaction Form Type: 4 transaction Code: S equity Swap Involved: 0 transaction Shares: 5000 id: F1 transaction Price Per Share: 7.8833 id: F2 transaction Acquired Disposed Code: D shares Owned Following Transaction: 208387 direct Or Indirect Ownership: D

Ordinary Shares

Owner: Menu Philippe
Date: 2026-09-14
Code: S
Action: Sale
Quantity: 5000
Price: 7.8833
Following holdings: 208,387
Reporting delay: 2 days
Filed terms and references: Filed terms
security Title: Ordinary Shares
transaction Date: 2026-09-14
transaction Form Type: 4
transaction Code: S
equity Swap Involved: 0
transaction Shares: 5000
id: F1
transaction Price Per Share: 7.8833
id: F2
transaction Acquired Disposed Code: D
shares Owned Following Transaction: 208387
direct Or Indirect Ownership: D

Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.

Filing context

Quantities and prices are shown in the units filed. No trade value is inferred from their product.
Menu Philippe: Chief Medical Officer.
The filing reports a Rule 10b5-1 trading plan.
F1: Transaction made pursuant to duly adopted trading plan under Rule 10b5-1(c).
F2: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $7.78 to $7.99, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Original sources

SEC ownership filing

Prepared automatically from public filing data. Report a correction.

Security

Owner

Date

Code

Action

Quantity

Price

Following holdings

Reporting delay

Filed terms and references

Ordinary Shares

Menu Philippe

2026-09-14

Sale

5000

7.8833

208,387

2 days

Filed terms

security Title: Ordinary Shares
transaction Date: 2026-09-14
transaction Form Type: 4
transaction Code: S
equity Swap Involved: 0
transaction Shares: 5000
id: F1
transaction Price Per Share: 7.8833
id: F2
transaction Acquired Disposed Code: D
shares Owned Following Transaction: 208387
direct Or Indirect Ownership: D

Filing context

Quantities and prices are shown in the units filed. No trade value is inferred from their product.

Menu Philippe: Chief Medical Officer.

The filing reports a Rule 10b5-1 trading plan.

F1: Transaction made pursuant to duly adopted trading plan under Rule 10b5-1(c).

F2: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $7.78 to $7.99, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.